BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Now more than ever\, exosome and EV therapies are on the verge
  of groundbreaking clinical and commercial breakthroughs. With recent mil
 estones like Aegle Therapeutics' clinical advances\, Kimera Labs' FDA app
 roval\, Capricor Therapeutics' collaboration on a COVID vaccine with the 
 NIH\, and NurExone Biologics' innovations in CNS treatments\, this summit
  is a must-attend event. Join us at the 6th Exosome-Based Therapeutics De
 velopment Summit in September to delve into groundbreaking advancements\,
  access exclusive clinical data\, and forge pivotal partnerships to defin
 e the future of exosome drug development.&nbsp\;\n\nSpanning the complete
  development cycle of exosome therapeutics from discovery through IND fil
 ing\, our summit uniquely integrates cutting-edge research with practical
  commercialization strategies. It stands as the sole industry meeting tha
 t bridges the gap between science and business\, propelling clinical adva
 ncements.&nbsp\;\n\nDon't miss the chance to connect with over 150 of the
  industry's leading experts in exosome therapeutics\, gain invaluable ins
 ights\, and place your work at the forefront of pharmaceutical innovation
 . Join us at the 6th Exosome-Based Therapeutics Development Summit and co
 ntribute to the evolving landscape of advanced extracellular vesicle drug
  development.\n\nURLs:Tickets:&nbsp\;https://go.evvnt.com/2433871-2?pid=1
 85Brochure:&nbsp\;https://go.evvnt.com/2433871-3?pid=185\n\nPrices:Confer
 ence + 3 Workshops (Full Access) - Industry Pricing: USD 4197.00\,Confere
 nce Only - Industry Pricing: USD 2999.00\,Conference + 3 Workshops (Full 
 Access) - Academic Pricing: USD 3597.00\,Conference Only - Academic Prici
 ng: USD 2599.00\,Conference + 3 Workshops (Full Access) - Service Provide
 r Pricing: USD 5097.00\,Conference + Only - Service Provider Pricing: USD
  3699.00\n\nSpeakers:&nbsp\;AJ Bergmann Chief Financial Officer Capricor 
 Inc.\, Banishree Saha Associate Director Takeda Pharmaceutical Co. Ltd.\,
  Carla Mazzeo Research and Development Director Regenerelle\, Celine Lark
 in Scientist OmniSpirant\, Christine Happel Program Director National Can
 cer Institute\, Chulhee Choi President ILIAS Biologics Inc.\, Driton Vlla
 saliu MPharm Course Director Kings College University\, Gary Hao Vice Pre
 sident - Chemistry\, Manufacturing and Controls Vesigen Therapeutics\, Ge
 rardo Rodriguez Chief Scientific and Medical Officer Exosome Therapeutics
 \, Gi-Hoon Nam Co-Founder and Chief Executive Officer SHIFTBIO INC. and K
 orea University College of Medicine\, Heidi Kempinski Chief Operating Off
 icer Aegle Therapeutics\, Hugues Wallemacq Chief Operating Officer EXO Bi
 ologics\, Jahan Jowharchi Chief of Technical Operations RION Health\, Jea
 n-Paul Prieels Chief Executive Officer convEyXO SA\, Jill Swartz Chief Pr
 oduct Officer ZeoScientific\, Lexie Shannon Holliday Associate Professor 
 University of Florida\, Linda Marban Chief Executive Officer Capricor Inc
 .\, Mansoor Amiji University Distinguished Professor Northeastern Univers
 ity\, Mercedes Kweh CEO Kwehealth\, MICHAEL DOHERTY Associate Director - 
 Process Development Ring Therapeutics\, Nazma Ilahibaks Founder Jama Ther
 apeutics\, Nicolas Rousseau Chief Operating Officer EVerZom\, Patricia Fr
 eire Research and Development Innovation Manager Exogenus Therapeutics\, 
 Qin Yu Vice President - Research Vesigen Therapeutics\, Rob Knight Lead S
 cientist Cellese\, Robin Smith Co-Founder Exotropin\, Tong Zhao Chief Exe
 cutive Officer TheraXyte Bioscience\, Tony Hu Presidential Chair and Prof
 essor Tulane University\, Viviana Hamilton Director\, CMC ArunA Bio\, Xen
 ia Sango CEO and MD VivaZome Therapeutics\, Yujia Jing Senior Director Xs
 ome\n\nCategory:&nbsp\;Conferences | Science\, Health and Medicine | Phar
 maceuticals\n\nDate and Time:&nbsp\;17th September 2024 at 9:00 am to 19t
 h September 2024 at 5:00 pm\n
DTEND:20240919T170000
DTSTAMP:20260512T231940Z
DTSTART:20240917T090000
LOCATION:Hilton Boston Logan Airport\, One\, Hotel Drive\, Boston\, Massac
 husetts\, 02128\,
SEQUENCE:0
SUMMARY:Now more than ever\, exosome and EV therapies are on the verge of 
 groundbreaking clinical and commercial breakthroughs. With recent milesto
 nes like...
UID:5ea15cfd-826d-419a-9289-26d6ec03e9da
END:VEVENT
END:VCALENDAR